182 related articles for article (PubMed ID: 37887106)
1. Extract2Chip-Bypassing Protein Purification in Drug Discovery Using Surface Plasmon Resonance.
Paiva ACF; Lemos AR; Busse P; Martins MT; Silva DO; Freitas MC; Santos SP; Freire F; Barrey EJ; Manival X; Koetzner L; Heinrich T; Wegener A; Grädler U; Bandeiras TM; Schwarz D; Sousa PMF
Biosensors (Basel); 2023 Oct; 13(10):. PubMed ID: 37887106
[TBL] [Abstract][Full Text] [Related]
2. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
Patching SG
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
[TBL] [Abstract][Full Text] [Related]
3. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
4. Surface plasmon resonance analysis of seven-transmembrane receptors.
Aristotelous T; Hopkins AL; Navratilova I
Methods Enzymol; 2015; 556():499-525. PubMed ID: 25857797
[TBL] [Abstract][Full Text] [Related]
5. Systematic Screening of Viral Entry Inhibitors Using Surface Plasmon Resonance.
Kumar PKR
Methods Mol Biol; 2020; 2089():131-145. PubMed ID: 31773651
[TBL] [Abstract][Full Text] [Related]
6. Algorithms for the automated selection of fragment-like molecules using single-point surface plasmon resonance measurements.
Kreatsoulas C; Narayan K
Anal Biochem; 2010 Jul; 402(2):179-84. PubMed ID: 20371355
[TBL] [Abstract][Full Text] [Related]
7. Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by combination of surface plasmon resonance biosensor and UPLC-MS.
Cao Y; Li YH; Lv DY; Chen XF; Chen LD; Zhu ZY; Chai YF; Zhang JP
Anal Bioanal Chem; 2016 Jul; 408(19):5359-67. PubMed ID: 27225174
[TBL] [Abstract][Full Text] [Related]
8. Protein-Protein Interactions: Surface Plasmon Resonance.
Douzi B
Methods Mol Biol; 2017; 1615():257-275. PubMed ID: 28667619
[TBL] [Abstract][Full Text] [Related]
9. SPRD: a surface plasmon resonance database of common factors for better experimental planning.
Tiwari PB; Bencheqroun C; Lemus M; Shaw T; Kouassi-Brou M; Alaoui A; Üren A
BMC Mol Cell Biol; 2021 Mar; 22(1):17. PubMed ID: 33676410
[TBL] [Abstract][Full Text] [Related]
10. Development of a multifunctional tool for drug screening against plasmodial protein-protein interactions via surface plasmon resonance.
Boucher LE; Bosch J
J Mol Recognit; 2013 Oct; 26(10):496-500. PubMed ID: 23996492
[TBL] [Abstract][Full Text] [Related]
11. SPR in drug discovery: searching bioactive compounds in plant extracts.
Minunni M; Bilia AR
Methods Mol Biol; 2009; 572():203-18. PubMed ID: 20694694
[TBL] [Abstract][Full Text] [Related]
12. Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR.
Gunnarsson A; Stubbs CJ; Rawlins PB; Taylor-Newman E; Lee WC; Geschwindner S; Hytönen V; Holdgate G; Jha R; Dahl G
SLAS Discov; 2021 Jun; 26(5):730-739. PubMed ID: 33289457
[TBL] [Abstract][Full Text] [Related]
13. Quick evaluation of kinase inhibitors by surface plasmon resonance using single-site specifically biotinylated kinases.
Kitagawa D; Gouda M; Kirii Y
J Biomol Screen; 2014 Mar; 19(3):453-61. PubMed ID: 24080257
[TBL] [Abstract][Full Text] [Related]
14. [Fragment screening using surface plasmon resonance optical biosensor technology].
Miura T
Yakugaku Zasshi; 2010 Mar; 130(3):341-8. PubMed ID: 20190519
[TBL] [Abstract][Full Text] [Related]
15. A combinatorial biophysical approach; FTSA and SPR for identifying small molecule ligands and PAINs.
Redhead M; Satchell R; Morkūnaitė V; Swift D; Petrauskas V; Golding E; Onions S; Matulis D; Unitt J
Anal Biochem; 2015 Jun; 479():63-73. PubMed ID: 25837771
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of angiotensin converting enzyme inhibitors by SPR biosensor and theoretical studies.
Salehabadi H; Khajeh K; Dabirmanesh B; Biglar M; Amanlou M
Enzyme Microb Technol; 2019 Jan; 120():117-123. PubMed ID: 30396392
[TBL] [Abstract][Full Text] [Related]
17. Surface Plasmon Resonance-Based Membrane Protein-Targeted Active Ingredients Recognition Strategy: Construction and Implementation in Ligand Screening from Herbal Medicines.
Chen L; Lv D; Wang S; Wang D; Chen X; Liu Y; Hong Z; Zhu Z; Cao Y; Chai Y
Anal Chem; 2020 Mar; 92(5):3972-3980. PubMed ID: 32045214
[TBL] [Abstract][Full Text] [Related]
18. Comparison of weak affinity chromatography and surface plasmon resonance in determining affinity of small molecules.
Duong-Thi MD; Bergström G; Mandenius CF; Bergström M; Fex T; Ohlson S
Anal Biochem; 2014 Sep; 461():57-9. PubMed ID: 24915639
[TBL] [Abstract][Full Text] [Related]
19. Surface Plasmon Resonance Method to Evaluate Anti-citrullinated Protein/Peptide Antibody Affinity to Citrullinated Peptides.
Real-Fernández F; Rossi G; Panza F; Pratesi F; Migliorini P; Rovero P
Methods Mol Biol; 2015; 1348():267-74. PubMed ID: 26424279
[TBL] [Abstract][Full Text] [Related]
20. Bioelectronic Measurement of Target Engagement to a Membrane-Bound Transporter.
Martinez WE; Arenas JE; Mok L; Wong NY; Lozano MM; Lin WC; Gutierrez MG; Sierra Chavera R; McGivern JG
SLAS Discov; 2021 Sep; 26(8):1004-1013. PubMed ID: 33980065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
